BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 2258069)

  • 1. The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women.
    Hagemann IS; Deng W; Zaino RJ; Powell MA; Gunderson C; Cosgrove C; Mathews C; Pearl ML; Waggoner S; Ghebre R; Lele S; Guntupalli S; Secord AA; Ioffe O; Park K; Rasty G; Singh M; Soslow R; Creasman W; Mutch DG
    Gynecol Oncol; 2021 Mar; 160(3):660-668. PubMed ID: 33423806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical issues in the diagnosis of serous carcinoma of the endometrium.
    Gatius S; Matias-Guiu X
    Mod Pathol; 2016 Jan; 29 Suppl 1():S45-58. PubMed ID: 26715173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cell type on surgico-pathologic risk factors in endometrial cancer.
    Turan AT; Dündar B; Gündoğdu B; Boztosun A; Ozgül N; Boran N; Tulunay G; Ozfuttu A; Köse MF
    J Turk Ger Gynecol Assoc; 2011; 12(1):9-14. PubMed ID: 24591950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium.
    Pradhan M; Davidson B; Abeler VM; Danielsen HE; Tropé CG; Kristensen GB; Risberg BÅ
    Virchows Arch; 2012 Sep; 461(3):291-8. PubMed ID: 22824999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of women with surgically staged 1 uterine papillary serous cancer.
    Elit L; Laroche A; Smith L; Mazurka J; Moens F; Hauspy J; Jimenez W
    ISRN Obstet Gynecol; 2011; 2011():146264. PubMed ID: 21918723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of minimal uterine serous carcinoma with distant lymph node metastasis without peritoneal dissemination.
    Kawano K; Ushijima K; Yokomine M; Fukui A; Ijichi M; Kamura T
    J Gynecol Oncol; 2011 Mar; 22(1):53-6. PubMed ID: 21607097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage and with aggressive histological phenotypes.
    Tsuda H; Hirohashi S
    Jpn J Cancer Res; 1992 Nov; 83(11):1184-91. PubMed ID: 1336492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine papillary serous carcinoma: a review.
    Dunton CJ; Balsara G; McFarland M; Hernandez E
    Obstet Gynecol Surv; 1991 Feb; 46(2):97-102. PubMed ID: 1997927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical aspects of uterine papillary serous carcinoma.
    Hamilton CA; Kapp DS; Chan JK
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):26-33. PubMed ID: 18197002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serous papillary carcinoma of the endometrium: a histopathological study of 22 cases.
    Abeler VM; Kjørstad KE
    Gynecol Oncol; 1990 Dec; 39(3):266-71. PubMed ID: 2258069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma.
    Carcangiu ML; Chambers JT
    Gynecol Oncol; 1992 Dec; 47(3):298-305. PubMed ID: 1473741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival advantage associated with multimodal therapy in women with node-positive (stage-IIIC) uterine papillary serous carcinoma: a National Cancer Database study.
    Lin JF; Muñiz K; Sukumvanich P; Gehrig P; Beriwal S; Kelley JL; Edwards RP; Olawaiye AB
    BJOG; 2016 Oct; 123(11):1846-52. PubMed ID: 26537059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serous papillary cancer of the endometrium].
    Karseladze AI
    Arkh Patol; 1987; 49(8):30-5. PubMed ID: 3675216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features.
    Sherman ME; Bitterman P; Rosenshein NB; Delgado G; Kurman RJ
    Am J Surg Pathol; 1992 Jun; 16(6):600-10. PubMed ID: 1599038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Survival Outcomes of Uterine Papillary Serous Carcinoma, Clear Cell Carcinoma, Grade 3 Endometrioid Adenocarcinoma, and Carcinosarcoma of Endometrial Cancer in Rajavithi Hospital.
    Prueksaritanond N; Chantape W
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S75-83. PubMed ID: 27266220
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.